CellaVision AB (publ)

Short Term Long Term Short Term Comparison Long Term Comparison
  • CEVI
  • 1d0.23%
  • 1w0.23%
  • 1m-4.53%
  • 1y26.11%
ATH
  • ATH Price$483.28
  • ATH Date2021-08-12
  • % since ATH-54.17%
  • % to ATH118.19%
ATL
  • ATL Price$3.55
  • ATL Date2008-12-17
  • % from ATL6,137.86%
  • Last Low Price$122.8
  • Last Low Date2023-10-19
  • % From Last Low80.37%
IPO
  • IPO Price$9.70
  • % Current ROI USD2,283.51%
  • ATH Price$483.28
  • % ROI ATH 1,361,012.70%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="CEVI"]

Key Data [addtoany]

Current price $221.5
Sector Healthcare
Industry Medical Devices
Today's High/Low $227.5/$221
Volume 4,795.00
Previous Close $221
52 Week High/Low $275/$120
Market Cap 5,283,107,328.00
P/E Ratio 40.4936
Forward P/E 1 Yr. $29.24
Earnings Per Share(EPS) $9.14
Annualized Dividend $0.0102
$221.5
[addtoany]
Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity